Evaluation of the inflammatory response in experimentally induced synovitis in the horse: A comparison of recombinant equine interleukin 1 beta and lipopolysaccharide

Osteoarthritis and Cartilage

Volumn 20, Issue 12, 2012, Pages 1583-1590

  Ross, T N ^a   Kisiday, J D ^a   Hess, T ^a   McIlwraith, C W ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Animal model; Arthritis; Cartilage; Inflammation; MRNA; Synovial tissue

Indexed keywords

AGGRECANASE 1; AGGRECANASE 2; DISINTEGRIN; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 1BETA; THROMBOSPONDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHROCENTESIS; ARTHROSCOPY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE BIOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; HORSE DISEASE; LEUKOCYTE COUNT; NEUTROPHIL COUNT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIAL FLUID; SYNOVITIS;

ADAM PROTEINS; ANIMALS; ARTHROSCOPY; BIOPSY; CARTILAGE, ARTICULAR; GENE EXPRESSION REGULATION; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 1; PROCOLLAGEN N-ENDOPEPTIDASE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; SYNOVITIS;

EID: 84867854479     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.08.008     Document Type: Article

References (42)

1. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev 2010, 6:625-635.
2. McIlwraith C.W. Frank Milne Lecture: from arthroscopy to gene therapy-30 years of looking in joints. Proceedings Am Assoc Equine Pract 2005, 51:65-113.
3. Frisbie D.D., Ghivizzani S.C., Robbins P.D., Evans C.H., McIlwraith C.W. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002, 9:12-20.
4. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
5. Malcolm D.S., Triantafillou S., Parker A., Youssef P.P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997, 24:365-371.
6. Blom A.B., van der Kraan P.M., van den Berg W.B. Cytokine targeting in osteoarthritis. Curr Drug Targets 2007, 8:283-292.
7. Pelletier J.P., Caron J.P., Evans C., Robbins P.D., Georgescu H.I., Jovanovic D., et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor anatagonist using gene therapy. Arthritis Rheum 1997, 40:1012-1019.
8. McIlwraith C.W., Fessler J.F., Blevins W.E., Page E.H., Rebar A.H., Vansickle D.C., et al. Experimentally induced arthritis of the equine carpus: clinical determinations. Am J Vet Res 1979, 40:11-20.
9. Todhunter P.G., Kincaid S.A., Todhunter R.J., Kammermann J.R., Johnstone B., Baird A.N., et al. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Am J Vet Res 1996, 57:1080-1092.
10. Firth E.C., Wensing T., Seuren F. An induced synovitis disease model in ponies. Cornell Vet 1987, 77:107-118.
11. Palmer J.L., Bertone A.L. Experimentally-induced synovitis as a model for acute synovitis in the horse. Equine Vet J 1994, 26:492-495.
12. 2 values in horses. Am J Vet Res 1993, 54:379-386.
13. deGrauw J.C., van de Lest C.H.A., van Weeren P.R. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009, 11(R35). online version. http://arthritis-research.com/content/11/2/R35.
14. Smith G., Bertone A.L., Kaeding C., Simmons E.J., Apostoles S. Anti-inflammatory effects of topically applied dimethyl sulfoxide gel on endotoxin-induced synovitis in horses. Am J Vet Res 1998, 59:1149-1152.
15. Santos L.C.P., Nunes de Moraes A., Saito M.E. Effects of intraarticular ropivacaine and morphine on lipopolysaccharide-induced synovitis in horses. Vet Anaesth Analg 2009, 36:280-286.
16. Kay A.T., Bolt D.M., Ishihara A., Rajala-Schultz P.J., Bertone A.I. Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetone, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses. Am J Vet Res 2008, 69:1646-1654.
17. Morton A.J., Campbell N.B., Gayle J.M., Redding W.R., Blikslager A.T. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Res Vet Sci 2005, 78:189-192.
18. Gottschalk R.D., Reyers F., van den Berg S.S. The effect of endotoxin and anti-endotoxin serum on synovial fluid parameters in the horse. J S Afr Vet Assoc 1998, 69:7-11.
19. Campebell R.C., Peiro J.R., Valadao C.A.A., Santana A.E., Cunha F.Q. Effects of lidocaine on lipopolysaccharide-induced synovitis in horses. Arq Bras Med Vet Zootec 2004, 56:281-291.
20. Verde C.R., Simpson M.I., Frigoli A., Landoni M.F. Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. J Vet Pharmacol Therap 2001, 24:179-185.
21. Hardy J., Bertone A., Weisbrode S.E., Muir W.W., O'Dorisio T.M., Masty J. Cell trafficking, mediator release and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. Am J Vet Res 1998, 59:88-100.
22. Pearson W., Orth M.W., Lindinger M.I. Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration. Am J Vet Res 2009, 70:848-861.
23. Scott I., Midha A., Rashid U., Ball S., Walding A., Kerry P., et al. Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1β-driven model of joint pathology. Osteoarthritis Cartilage 2009, 17:790-797.
24. 2 synthesis in equine articular cartilage explants. Am J Vet Res 2002, 63:551-558.
25. Henneke D.R., Potter G.D., Kreider J.R., Yeates B.F. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983, 15:371-372.
26. DePuy T., Howard R., Keegan K., Wilson D., Kramer J., Cook J.L., et al. Effects of intra-articular botulinum toxin type A in an equine model of acute synovitis. Am J Phys Med Rehabil 2007, 86:777-783.
27. Anonymous Guide for Veterinary Services and Judging of Equestrian Events 1991, Am Assoc Equine Pract, 19. 4th edn.
28. Frisbie D.D., Kawcak C.M., Baxter G.M., Trotter G.W., Powers B.E., Lassen E.D., et al. Effects of 6alpha-methylprednisolone acetate on an equine osteochondral fragment exercise model. Am J Vet Res 1998, 59:1619-1628.
29. Kisiday J.D., Vanderploeg E.J., McIlwraith C.W., Grodzinsky A.J., Frisbie D.D. Mechanical injury of explants from the articulating surface of the inner meniscus. Arch Biochem Biophys 2010, 494:138-144.
30. McIlwraith C.W. Diseases of joints, tendons, ligaments and related structures. Adams' Lameness in Horses 2002, 483. Lippincott, Williams and Wilkins, Philadelphia. 5th edn. T.S. Stashak (Ed.).
31. Todhunter R.J. Anatomy and physiology of synovial joints. Joint Disease in the Horse 1996, 1-28. WB Saunders Co, Philadelphia. C.W. McIlwraith, G.W. Trotter (Eds.).
32. 2 and glycoaminoglycans in healthy equine joints. Equine Vet J 2005, 37:250-256.
33. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002, 46:2648-2657.
34. Bondeson J., Wainwright S.D., Lauder S., Amos N., Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
35. Busschers E., Holt J.P., Richardson D.W. Effects of glucocorticoids and interleukin-1β on expression and activity of aggrecanases in equine chondrocytes. Am J Vet Res 2010, 71:176-185.
36. Bondeson J., Wainwright S., Hughes C., Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol 2008, 26:139-145.
37. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
38. Fosang A.J., Rogerson F.M., East C.J., Stanton H. ADAMTS-5: the story so far. Euro Cells Mater 2008, 15:11-26.
39. Shirazi I., Yaron I., Wollman M., Chernihovsky T., Judovick R., Iaina A., et al. Down regulation of interleukin 1β production in human osteoarthritic synovial tissue and cartilage cultures by aminoguanidine. Ann Rheum Dis 2001, 60:391-394.
40. Yaron M., Shirazi I., Yaron I. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage 1999, 7:272-280.
41. Matsukawa A., Ohkawara S., Maeda T., Takagi K., Yoshinaga M. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccaharide-induced arthritis in rabbits. Clin Exp Immunol 1993, 93:206-211.
42. May S.A., Hooke R.E., Lees P. The characterization of equine interleukin-1. Vet Immunol Immunopathol 1990, 24:169-217.